Trade Name: Kristalose

Following information is meant for : Wholesalers, Suppliers, Exporters, Doctors, CROs, Comparator Supplies, Hospitals, MOH Tender Supplies, Generic, Brand, Cooperate Sourcing, India, Institutional Buyers.

Manufacturer: Cumberland Pharmaceuticals Inc.

Presentation: POWDER, FOR SOLUTION, HUMAN PRESCRIPTION DRUG

Strength: 10 g/10g

Storage and handling

LACTULOSE Osmotic Laxative [EPC],Osmotic Activity [MoA],Acidifying Activity [MoA],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Disclaimer:
  1. These products are NOT FOR SALE in US territories. We offer them for Exports outside of US Territories to Trade Professionals or patients with a valid prescription.
  2. Trademark shown are property of their respective owners and GNH India does not lay any claim on them.
  3. Read more
  • No data
  • KRISTALOSE (lactulose) is a synthetic disaccharide in the form of crystals for reconstitution prior to use for oral administration Each 10 g of lactulose contains less than 0.3 g galactose and lactose as a total sum. The pH range is 3.0 to 7.0.n
  • Lactulose is a colonic acidifier which promotes laxation.n
  • The chemical name for lactulose is 4-O-u03b2-D-Galactopyranosyl-D-fructofuranose. It has the following structural formula:n
  • The molecular formula is CHO. The molecular weight is 342.30. It is freely soluble in water.n
  • KRISTALOSE (LACTULOSE) is poorly absorbed from the gastrointestinal tract and no enzyme capable of hydrolysis of this disaccharide is present in human gastrointestinal tissue. As a result, oral doses of lactulose reach the colon virtually unchanged. In the colon, lactulose is broken down primarily to lactic acid, and also to small amounts of formic and acetic acids, by the action of colonic bacteria, which results in an increase in osmotic pressure and slight acidification of the colonic contents. This in turn causes an increase in stool water content and softens the stool.n
  • Since lactulose does not exert its effect until it reaches the colon, and since transit time through the colon may be slow, 24 to 48 hours may be required to produce desired bowel movement.n
  • Lactulose given orally to man and experimental animals resulted in only small amounts reaching the blood. Urinary excretion has been determined to be 3% or less and is essentially complete within 24 hours.n
  • KRISTALOSE (LACTULOSE) For Oral Solution is indicated for the treatment of constipation. In patients with a history of chronic constipation, lactulose therapy increases the number of bowel movements per day and the number of days on which bowel movements occur.n
  • Since KRISTALOSE (LACTULOSE) For Oral Solution contains galactose (less than 0.3 g/10 g as a total sum with lactose), it is contraindicated in patients who require a low galactose diet.n
  • A theoretical hazard may exist for patients being treated with lactulose who may be required to undergo electrocautery procedures during proctoscopy or colonoscopy. Accumulation of H gas in significant concentration in the presence of an electrical spark may result in an explosive reaction. Although this complication has not been reported with lactulose, patients on lactulose therapy undergoing such procedures should have a thorough bowel cleansing with a non-fermentable solution. Insufflation of CO as an additional safeguard may be pursued but is considered to be a redundant measure.n
  • No data
  • Precise frequency data are not available.n
  • Initial dosing may produce flatulence and intestinal cramps, which are usually transient. Excessive dosage can lead to diarrhea with potential complications such as loss of fluids, hypokalemia, and hypernatremia.n
  • Nausea and vomiting have been reported.n
  • No data
  • The usual adult dosage is 10 g to 20 g of lactulose daily. The dose may be increased to 40 g daily if necessary. Twenty-four to 48 hours may be required to produce a normal bowel movement.n
  • Dissolve contents of packet in half a glass (4 ounces) of water.n
  • When Lactulose For Oral Solution is dissolved in water, the resulting solution may be colorless to a slightly pale yellow color.n
  • KRISTALOSE (LACTULOSE) For Oral Solution is available in single dose packets of 10 g (NDC 66220-719-01) and single dose packets of 20 g (NDC 66220-729-01). The packets are supplied as follows:n
  • STORE AT ROOM TEMPERATURE, 15u00b0-30u00b0C (59u00b0-86u00b0F).
  • To report SUSPECTED ADVERSE REACTIONS, contact Cumberland Pharmaceuticals Inc. at 1-877-484-2700 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
  • Manufactured for:CUMBERLANDPHARMACEUTICALS INC.Nashville, TN 37203KRISTALOSE is a registered trademark of Cumberland Pharmaceuticals Inc.Issued: July 2018n
  • Principal Display panel u2013 10 Grams Carton Labeln
  • NDC 66220-719-30n
  • Kristalosen- ( lactulose )For Oral Solution
  • 10 Gramsn
  • CUMBERLANDn
  • PHARMACEUTICALSn
  • Rx only
  • Principal Display Panel u2013 10 Grams Pouch Labeln
  • NDC 66220-719-01n n n n
  • CUMBERLANDn
  • PHARMACEUTICALSn
  • 10 Gramsn
  • Rx only
  • CONTENTS:
  • This unit dose packet is not child resistant.n
  • INDICATIONS:
  • USUAL ADULT DOSAGE:
  • Since lactulose does not exert its effect until it reaches the colon, and since transit time through the colon may be slow, 24-48 hours may be required to produce a normal bowl movement.n
  • DIRECTIONS FOR PREPARATION:
  • Store at room temperature, 15u00b0-30u00b0C (59u00b0-86u00b0F).n
  • Manufactured for:Cumberland Pharmaceuticals Inc.Nashville, TN, USA, 37203
  • Principal Display panel u2013 20 Grams Carton Labeln
  • NDC 66220-729-30n
  • Kristalosen- ( lactulose )For Oral Solution
  • 20 Gramsn
  • CUMBERLANDn
  • PHARMACEUTICALSn
  • Rx only
  • Principal Display Panel u2013 20 Grams Pouch Labeln
  • NDC 66220-729-01n n n n
  • CUMBERLANDn
  • PHARMACEUTICALSn
  • 20 Gramsn
  • Rx only
  • CONTENTS:
  • This unit dose packet is not child resistant.n
  • INDICATIONS:
  • USUAL ADULT DOSAGE:
  • Since lactulose does not exert its effect until it reaches the colon, and since transit time through the colon may be slow, 24-48 hours may be required to produce a normal bowl movement.n
  • DIRECTIONS FOR PREPARATION:
  • Store at room temperature, 15u00b0-30u00b0C (59u00b0-86u00b0F).n
  • Manufactured for:Cumberland Pharmaceuticals Inc.Nashville, TN, USA, 37203

Ask for Quote

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler, Supplier, Exporters from India of lactulose (Kristalose) which is also known as Kristalose and Manufactured by Cumberland Pharmaceuticals Inc.. It is available in strength of 10 g/10g.

lactulose (Kristalose) is supplied for Tenders, Emergency imports, Un - licensed, Specials, Orphan drug, Name patient line, RLD supplies, Reference listed drugs, Comparator Drug, Bio-Similar, Innovator samples, For Clinical trials. Click to know price.

Browse Our Services And Processes

Name Patient Supply

Name Patient Supply

Validated Cold Chain Shipment

Validated Cold Chain Shipment

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

Our Process - The Gnh Way

Our Process - The Gnh Way

Other Pharmaceutical Products

Fluorouracil - 5 Flucel -250mg

Fluorouracil - 5 Flucel -250mg

Liposomal Amphotericin - B for Injection IP (AmBisome)

Liposomal Amphotericin - B for Injection IP (AmBisome)

Edatate Calcium Disodium Injection USP 200mg/ml (Cal-Rsodate)

Edatate Calcium Disodium Injection USP 200mg/ml (Cal-Rsodate)

Melphalan Injection IP 50mg (Alkacel)

Melphalan Injection IP 50mg (Alkacel)

Monobenzone Cream USP 20% (Albaquin)

Monobenzone Cream USP 20% (Albaquin)

Beclomethasone Dipropionate and Levosalbutamol Inhaler (Aerocort)

Beclomethasone Dipropionate and Levosalbutamol Inhaler (Aerocort)

Are you an existing customer or a vendor of GNH India? Log in here to